Healthcare >> CEO Interviews >> December 22, 2000
Dr Alastair Riddell is Chief Executive Officer of Pharmagene PLC.
He was appointed Chief Executive Officer of Pharmagene plc in January 1998, joining from Caremark (UK) Ltd. where he was Managing Director. His career began in biological research and then medicine, including six years in acute hospital specialities and general practice. He entered the pharmaceutical industry in 1983 holding senior clinical development posts in Lederle, Xoma, Celltech and Centocor before moving to sales and marketing. He was worldwide head of marketing for the healthcare division of Amersham International before being made General Manager of its Northern Europe organisation. Dr. Riddell is responsible for setting the strategic direction of the company and its commercial plans. Profile
Dr. Riddell: Pharmagene is a drug discovery
